First Trust Direct Indexing’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,069
Closed -$419K 724
2023
Q1
$419K Buy
9,069
+348
+4% +$16.2K 0.05% 452
2022
Q4
$404K Buy
8,721
+621
+8% +$28.2K 0.05% 435
2022
Q3
$355K Buy
8,100
+583
+8% +$26.8K 0.05% 425
2022
Q2
$318K Sell
7,517
-176
-2% -$7.46K 0.04% 456
2022
Q1
$335K Sell
7,693
-330
-4% -$15.3K 0.04% 469
2021
Q4
$426K Sell
8,023
-39
-0.5% -$1.96K 0.06% 394
2021
Q3
$383K Buy
8,062
+405
+5% +$20.1K 0.05% 409
2021
Q2
$348K Buy
7,657
+342
+5% +$15.5K 0.05% 428
2021
Q1
$313K Buy
7,315
+93
+1% +$3.86K 0.08% 300
2020
Q4
$299K Buy
+7,222
New +$285K 0.08% 287

Other funds holding G

First Trust Direct Indexing's G Position: Q2 2023 in Review

First Trust Direct Indexing sold out of Genpact (G) in Q2 2023, closing a stake of 9,069 shares — an estimated $419K sold.

First Trust Direct Indexing first reported a position in G in Q4 2020 and held it in 10 quarters. The position peaked at $426K in Q4 2021. 356 funds tracked by Wall St. Rank hold G as of Q2 2023.

  • First Trust Direct Indexing reported no remaining Genpact position as of Q2 2023 after selling out during the quarter.
  • First Trust Direct Indexing sold 9,069 Genpact shares in Q2 2023, an estimated $419K.
  • First Trust Direct Indexing first reported a position in Genpact in Q4 2020 and held it in 10 quarters.
  • First Trust Direct Indexing's Genpact position peaked at $426K in Q4 2021.
  • 356 funds tracked by Wall St. Rank held Genpact as of Q2 2023.

Based on First Trust Direct Indexing's 13F filing for Q2 2023, filed 14 Jul 2023.